El-Heneidy, A. (2026) “Nirsevimab provides age-specific protection against RSV hospitalisation in the first year of life: a population-level study in Queensland, Australia”, Communicable Diseases Intelligence, 50. doi: 10.33321/cdi.2026.50.066.